Abstract
A 63-year-old man with prostate cancer was treated with prostatectomy who had postoperative PSA of 0.6 ng/mL. A pelvic MRI, whole body bone scan, CT chest and abdomen exams did not show any residual or metastatic prostate disease. His PSA increased to 0.9 ng/mL in two months. A fluciclovine PET did not show any tracer avid metastatic or recurrent disease. A 0.7 cm non-fluciclovine-avid nodule at the left prostatectomy bed was considered benign. A 68Ga-PSMA-11 PET one month later showed avid radiotracer uptake within this nodule. The patient received androgen deprivation treatment after PSMA PET/CT and responded well.
Original language | English (US) |
---|---|
Pages (from-to) | 378-379 |
Number of pages | 2 |
Journal | Clinical nuclear medicine |
Volume | 47 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2022 |
Keywords
- F-fluciclovine PET
- Ga-PSMA-11 PET
- metastasis
- MRI
- prostate cancer
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging